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summaries
lonG-term therapeutic outcomes 
Immunohematopoietic stem cell transplantation in 
Cape Town: a ten-year outcome analysis in adults
Wood and colleagues reviewed the outcomes over 10 years of 247 
adults who underwent hematopoietic stem cell transplantation at 
their institution in South Africa. There were no withdrawals and 
63% survived to the end of the study period. Median survival was 
3.3 years for acute lymphoblastic anemia, 3.1 years for acute myeloid 
leukemia, 2.8 years for chronic granulocytic leukemia, 2.8 years for 
lymphoma, 1.5 years for myeloma, 1.43 years for aplasia, and 1.4 
years for a miscellaneous group comprising less than 10 examples 
each. Multivariate analysis showed that only diagnosis and age had 
a significant impact on survival, but these two variables might be 
interrelated. The results confirm that procedures carried out in a 
properly constituted and dedicated unit, which meets established 
criteria and strictly observes treatment protocols, generate results 
comparable to those in a First World referral center.
Long-term outcome of adult acute lymphoblastic 
leukemia in Lebanon: a single institution 
experience from the American University of Beirut
Charafeddine and colleagues report on predictive and prognostic 
factors in adult patients with ALL treated at a tertiary care center 
in a developing country. Of 105 patients with acute leukemia, 36 
(34%) had ALL. Induction chemotherapy was administered to 
34 patients. The median overall survival time was 22 months and 
the 5-year disease-free survival was 38%. Age <40 years, WBC 
<30×109/L, achievement of complete remission after first induc-
tion and CNS prophylaxis were predictive for overall and disease-
free survival. Despite the relatively low socioeconomic status of 
the Lebanese population, survival rates were similar to interna-
tional data.
multimodalitY therapY
Multimodality treatments in locally advanced stage 
thymomas
Hassan and Seoud studied nine patients with newly diagnosed, 
histologically proven, unresectable malignant stage III and IVA 
thymoma who underwent a multimodality treatment regimen 
that consisted of neoadjuvant chemotherapy, followed by surgical 
resection, postoperative radiation therapy, and consolidation che-
motherapy. The overall response to neoadjuvant chemotherapy 
was 77%.   Tumors were removed completely in 5 patients and in-
completely in 3 patients; 1 patient refused surgery. Seven patients 
were alive at 4 years and 6 patients were disease free at 4 years. 
The authors concluded that multimodality treatment contributed 
to a good long-term outcome.
cancer epidemioloGY
Thyroid carcinoma in Pakistan: a retrospective 
review of 998 cases from an academic referral 
center 
Bukhari and colleagues reviewed thyroid lesions reported over a 
5-year period at a referral center in Karachi. Of 153 malignant 
cases, papillary carcinoma was commonest, with a frequency of 
90.2%. Females predominated (82.4%) for a female-to-male ratio 
of 4.7:1. Papillary, medullary, and follicular carcinomas occurred 
most often in the third and fourth decade of life.
hematoloGic disorders
Nosocomial sepsis-induced late onset 
thrombocytopenia in a neonatal tertiary care unit: 
a prospective study
Charoo and colleagues investigated the incidence of thrombo-
cytopenia in LOS patients and studied the influence of various 
parameters on platelet response. In 200 patients with culture-
proven nosocomial sepsis, 119 (59.5%) developed thrombocy-
topenia. Klebsiella pneumoniae was the most common pathogen 
and the incidence of thrombocytopenia was 60% in those pa-
tients. The incidence of thrombocytopenia was 90.3% among 
the 31 patients that had concurrent bacterial and fungal sepsis. 
Thrombocytopenia was highest among preterm and low-birth-
weight babies. Severity of thrombocytopenia was related to the 
presence of necrotizing enterocolitis and disseminated intravas-
cular coagulation. The mortality rate was significantly related to 
the degree of thrombocytopenia.
Predictors of severe hemolysis in patients with 
glucose-6-phosphate dehydrogenase deficiency 
following exposure to oxidant stresses
Al-Sweedan and colleagues reviewed the records of 428 children 
with G6PD deficiency, 79 (18%) of which were severe and 349 
(82%) were mild. The only factors that were statistically signifi-
cant for severe hemolysis were younger age, male gender, higher 
alkaline phosphatase, the presence of fever on admission, the pres-
ence of vomiting during the attack, and a negative family history 
for G6PD deficiency. These factors might serve as predictors of 
severe hemolysis in in children with low G6PD during episodes 
of hemolytic activity.
